IMC Chicago
GSK icon

IMC Chicago’s GSK GSK Stock Holding History

IMC Chicago’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.96M Sell
108,000
-42,700
-28% -$2.31M ﹤0.01% 1642
2025
Q4 		$7.39M Sell
150,700
-19,200
-11% -$895K ﹤0.01% 1448
2025
Q3 		$7.33M Buy
169,900
+5,500
+3% +$215K ﹤0.01% 1324
2025
Q2 		$6.31M Sell
164,400
-23,000
-12% -$879K ﹤0.01% 1250
2025
Q1 		$7.26M Buy
187,400
+4,900
+3% +$179K ﹤0.01% 1029
2024
Q4 		$6.17M Buy
182,500
+90,600
+99% +$3.26M ﹤0.01% 1138
2024
Q3 		$3.76M Sell
91,900
-97,600
-52% -$3.99M ﹤0.01% 1276
2024
Q2 		$7.3M Buy
189,500
+74,600
+65% +$3.14M ﹤0.01% 901
2024
Q1 		$4.93M Sell
114,900
-1,400
-1% -$57.7K ﹤0.01% 974
2023
Q4 		$4.31M Sell
116,300
-22,700
-16% -$815K ﹤0.01% 931
2023
Q3 		$5.04M Buy
139,000
+128,400
+1,211% +$4.56M ﹤0.01% 734
2023
Q2 		$378K Sell
10,600
-22,100
-68% -$793K ﹤0.01% 1216
2023
Q1 		$1.16M Sell
32,700
-86,900
-73% -$3.04M ﹤0.01% 992
2022
Q4 		$4.2M Sell
119,600
-3,500
-3% -$117K 0.01% 649
2022
Q3 		$3.62M Buy
123,100
+75,260
+157% +$2.85M ﹤0.01% 626
2022
Q2 		$2.6M Buy
47,840
+2,800
+6% +$155K ﹤0.01% 651
2022
Q1 		$2.45M Buy
+45,040
New +$2.45M ﹤0.01% 729
2021
Q2 		– Sell
-8,400
Closed -$375K – 1138
2021
Q1 		$375K Sell
8,400
-17,120
-67% -$777K ﹤0.01% 979
2020
Q4 		$1.17M Sell
25,520
-6,880
-21% -$316K ﹤0.01% 818
2020
Q3 		$1.52M Buy
32,400
+20,480
+172% +$1.03M ﹤0.01% 641
2020
Q2 		$608K Sell
11,920
-21,840
-65% -$1.12M ﹤0.01% 781
2020
Q1 		$1.6M Buy
+33,760
New +$1.8M ﹤0.01% 549

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IMC Chicago's GSK Position: Q4 2025 in Review

IMC Chicago sold out of GSK (GSK) in Q4 2025, closing a stake of 41,319 shares — an estimated $1.93M sold.

IMC Chicago first reported a position in GSK in Q3 2020 and held it in 8 quarters. The position peaked at $2.31M in Q4 2022. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • IMC Chicago reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 41,319 GSK shares in Q4 2025, an estimated $1.93M.
  • IMC Chicago first reported a position in GSK in Q3 2020 and held it in 8 quarters.
  • IMC Chicago's GSK position peaked at $2.31M in Q4 2022.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.